GB2425309B - C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers - Google Patents

C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers

Info

Publication number
GB2425309B
GB2425309B GB0614749A GB0614749A GB2425309B GB 2425309 B GB2425309 B GB 2425309B GB 0614749 A GB0614749 A GB 0614749A GB 0614749 A GB0614749 A GB 0614749A GB 2425309 B GB2425309 B GB 2425309B
Authority
GB
United Kingdom
Prior art keywords
benzodiazepine dimers
pyrrolo
fluoro
fluoro pyrrolo
benzodiazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0614749A
Other versions
GB2425309A (en
GB0614749D0 (en
Inventor
Ahmed Kamal
Peram Surakattula Murali Reddy
Depatla Rajasekhar Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of GB0614749D0 publication Critical patent/GB0614749D0/en
Publication of GB2425309A publication Critical patent/GB2425309A/en
Application granted granted Critical
Publication of GB2425309B publication Critical patent/GB2425309B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB0614749A 2003-12-31 2003-12-31 C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers Expired - Fee Related GB2425309B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000448 WO2005063758A1 (en) 2003-12-31 2003-12-31 C2-FLUORO PYRROLO[2,1-c][1,4]BENZODIAZEPINE DIMERS

Publications (3)

Publication Number Publication Date
GB0614749D0 GB0614749D0 (en) 2006-09-06
GB2425309A GB2425309A (en) 2006-10-25
GB2425309B true GB2425309B (en) 2008-07-09

Family

ID=34717565

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0614749A Expired - Fee Related GB2425309B (en) 2003-12-31 2003-12-31 C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers

Country Status (4)

Country Link
JP (1) JP4833663B2 (en)
AU (1) AU2003300705A1 (en)
GB (1) GB2425309B (en)
WO (1) WO2005063758A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2453402B (en) * 2006-02-13 2010-12-22 Council Scient Ind Res Novel bis-pyrrolo[2,1.-c] [1,4] benzodiazepine-anthraquinone conjugates and a process for the preparation thereof
ATE492550T1 (en) * 2006-03-10 2011-01-15 Council Scient Ind Res NEW BIS-2-DIFLUORPYRROLOÄ2,1-CÜÄ1, 4ÜBENZODIAZEPINEDIMERS
US8383618B2 (en) 2008-03-11 2013-02-26 Council Of Scientific & Industrial Research C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof
PE20181302A1 (en) * 2015-12-04 2018-08-09 Abbvie Stemcentrx Llc NEW ANTI-CLAUDIN ANTIBODIES AND THEIR METHODS OF USE
IL301637B2 (en) 2017-09-29 2024-10-01 Daiichi Sankyo Co Ltd Conjugation of an antibody with a pyrrolobenzodiazepine derivative
CN120936604A (en) * 2023-04-13 2025-11-11 广州百济神州生物制药有限公司 Targeting pyrrolobenzo Diazepine conjugates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018045A1 (en) * 1992-03-09 1993-09-16 Cancer Research Campaign Technology Limited Anti-cancer pyrrolobenzodiazepine derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018045A1 (en) * 1992-03-09 1993-09-16 Cancer Research Campaign Technology Limited Anti-cancer pyrrolobenzodiazepine derivatives

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal Chemistry Vol. 45, 2002, pages 4679-4688 *
Journal of Medicinal Chemsitry Vol. 44, No. 5, 2001, pages 737-748 *
Journal of Organic Chemistry Vol. 61, No. 23, 1996, pages 8141-8147 *

Also Published As

Publication number Publication date
GB2425309A (en) 2006-10-25
JP4833663B2 (en) 2011-12-07
AU2003300705A1 (en) 2005-07-21
WO2005063758A1 (en) 2005-07-14
JP2007518671A (en) 2007-07-12
GB0614749D0 (en) 2006-09-06

Similar Documents

Publication Publication Date Title
AP2002002695A0 (en) Pyrrolo Ä2,3-dÜpyrimidine compounds
EP1653969A4 (en) Pyrrolo 1,2-b pyridazine derivatives
GB0416511D0 (en) Pyrrolobenzodiazepines
PL1699795T3 (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives
EP1599482A4 (en) Pyrazolo 1,5-a pyrimidine derivatives
GB0325143D0 (en) Datacasting
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
IL167543A0 (en) Desalinization still
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
ZA200501679B (en) Recreation range.
IL172592A0 (en) Pyrazolopyrimidines
ZA200509884B (en) 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
IL172098A0 (en) Triazolopyrimidines
PL372989A1 (en) Triazolopyrimidines
MXPA03002649A (en) Benzodiazepine derivative.
ZA200510276B (en) Triazolopyrimidines
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
AU2003226725A8 (en) Pyrazolopyrimidine derivatives
GB2424883B (en) Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids
TWI350836B (en) 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
GB2424884B (en) C-8 linked pyrrolo[2,1-c][1,4]benzodiazepine-acridone/acridine hybrids
ZA200510374B (en) Pyrazolopyrimidines
AU2003227258A1 (en) Benzodiazepine derivative
GB0130351D0 (en) Cyclisation process
IL173347A0 (en) 7-SUBSTITUTED 3-NITRO-PYRAZOLO[1,5-a] PYRIMIDINES

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20171231